Medpace Holdings (MEDP) Gains from Investment Securities (2015 - 2026)
Medpace Holdings (MEDP) reported Gains from Investment Securities of -$66000.0 for Q1 2026, down 842.86% on a YoY basis from $8884.6 in Q1 2025, and down 100.17% quarter-over-quarter from $39.3 million in Q4 2025.
Medpace Holdings (MEDP) Gains from Investment Securities (2015 - 2026) Analysis & Trends
Medpace Holdings has reported Gains from Investment Securities for 12 years, with the latest figure at -$66000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 842.86% year-over-year to -$66000.0; the trailing twelve-month figure through Mar 2026 stood at $39.7 million (up 417.86% YoY), and the FY2025 full-year result was $39.7 million, up 582.03% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$66000.0, down from $39.3 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $39.3 million in Q4 2025, with the low at -$12.3 million in Q2 2024.
- Historically, Gains from Investment Securities has averaged $1.8 million across 5 years, with a median of -$51000.0 in 2024.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities slumped 2119.06% — and 2025, when it soared 48601.23%.
- Medpace Holdings' Gains from Investment Securities stood at $1.5 million in 2022, then sank by 276.8% to -$2.7 million in 2023, then jumped by 96.97% to -$81000.0 in 2024, then soared by 48601.23% to $39.3 million in 2025, then sank by 100.17% to -$66000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$66000.0 (Q1 2026), $39.3 million (Q4 2025), and -$87000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Medpace Holdings | 13.30 Bn | 12.64 Bn | 196.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66,000.00 |
| Mar 31, 2026 | -66,000.00 |
| Dec 31, 2025 | 39.29 Mn |
| Dec 31, 2025 | 39.29 Mn |
| Sep 30, 2025 | -87,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Jun 30, 2025 | 527,000.00 |
| Jun 30, 2025 | 527,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Dec 31, 2024 | -81,000.00 |
| Dec 31, 2024 | -81,000.00 |
| Sep 30, 2024 | -51,000.00 |
| Sep 30, 2024 | -51,000.00 |
| Jun 30, 2024 | -12.34 Mn |
| Jun 30, 2024 | -12.34 Mn |
| Mar 31, 2024 | 4.23 Mn |
| Mar 31, 2024 | 4.23 Mn |
| Dec 31, 2023 | -2.68 Mn |
| Dec 31, 2023 | -2.68 Mn |